LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

A case of multiple nodular cutaneous B‐cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine

Photo by nci from unsplash

Cutaneous pseudolymphomas (CPL) is a group of benign, reactive, and polyclonal lymphoproliferative dermatoses that simulate cutaneous lymphomas (CL) clinically and histologically. Based on the predominating component of lymphocytic infiltrate, CPL… Click to show full abstract

Cutaneous pseudolymphomas (CPL) is a group of benign, reactive, and polyclonal lymphoproliferative dermatoses that simulate cutaneous lymphomas (CL) clinically and histologically. Based on the predominating component of lymphocytic infiltrate, CPL can be divided into cutaneous B‐cell pseudolymphomas (CBPL), cutaneous T‐cell pseudolymphomas (CTPL), mixed (T‐/B‐cell) pseudolymphomas, CD30‐positive pseudolymphomas, and non‐classifiable pseudolymphomas. Most patients with localized nodular CBPL present with a solitary nodule. However, few patients develop multiple skin lesions, rarely in generalized forms. Here we describe a rare case of multiple nodular CBPL on both sides of the patient's neck, which was treated successfully with intramuscular injection of compound betamethasone, oral methotrexate, and hydroxychloroquine for 4 months. No recurrence was observed in the patient at the one‐year follow‐up. This combined treatment may be a promising treatment choice for multiple nodular CBPL.

Keywords: methotrexate hydroxychloroquine; cell; pseudolymphomas; case multiple; cutaneous cell; multiple nodular

Journal Title: Dermatologic Therapy
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.